Xin Ning
Guangxi Medical University
6 Papers
6 Citations
Xin Ning is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma
Xiwen Liao,Rui Huang,Xiaoguang Liu,Chuangye Han,Long Yu,Shijun Wang,Na Sun,Bopei Li,Xin Ning,Tao Peng +9 more
TL;DR: The data suggest that ADH1A, ADH5, and ADH6 expression may be potential prognostic markers of PAAD and in combination have a strong interaction and better predictive value for PAAD prognosis.
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.
Xin Ning,Yaoliang Deng +1 more
TL;DR: Genes and pathways related to cell cycle and DNA damage and repair may play a crucial role in BUC pathogenesis, whereas those pertaining to tumor angiogenesis may be key factors in influencing BUC prognosis, especially in advanced disease stages.
23
Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway
Fanling Meng,Jing Ding,Wei Xu,Chang Luo,Xi-Hai Chen,Rui Zhang,Lin Sui,Yuan Jing Hu,Shuang Liu,Guangyue Shi,Yunlong He,Xin Ning,Rong Ma,Ningou Huang +13 more
TL;DR: Investigation of the role of TRIM44 in epithelial ovarian cancer and its clinical implications suggest that it could be a potential therapeutic target for ovarian carcinoma through suppression of the FOXM1-EZH2 signaling pathway.
GBAS Regulates the Proliferation and Metastasis of Ovarian Cancer Cells by Combining with eEF1A1
Xin Ning,Guangyue Shi,Sujing Ren,Shuang Liu,Jing Ding,Ruizhu Zhang,Lianwei Li,Q L Xie,Wei Xu,Fanling Meng,Rong Ma +10 more
TL;DR: In this article , the expression, prognostic significance, and possible pathways of GBAS in ovarian cancer (OC) were investigated, and an in vitro tumor formation experiment in mice was constructed to prove the effect of the GBAS expression on the growth of OC in vivo.
Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia
B Cai,Yi Wang,Yangyang Lei,Yanping Shi,Qi-Yun Sun,Jian-Hui Qiao,Kai-Xun Hu,Yaqing Lei,Bing-Xia Li,Tie-Qiang Liu,Zhiqing Liu,Bo Yao,Xuecong Zhao,Xiaofei Li,Wen Zhao,Xiaoling Feng,Anli Xie,Xin Ning,Ming Feng,Weiwei Zhao,Jiayue Guo,Hui-Sheng Ai,Chang-Lin Yu,Mei Guo +23 more
TL;DR: Multivariate analyses demonstrated that white blood cells <30 × 109/L at diagnosis and sufficient hyper-CVAD cycles were prognostic factors for better 4-year OS and LFS, while the B-cell phenotype and higher number of infused CD34+ cells in the first cycle were predictors for favorable 4- year LFS.